Akorn-Strides sells product portfolio to Pfizer
Pfizer Inc. is acquiring 16 ANDAs and six filed ANDAs from Akorn-Strides LLC (a 50/50 joint venture between Akorn Inc. and Strides Arcolab Ltd.).
- Generic Drugs
- Marketing (Licensing)
- Product Purchase
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.